Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Videos
Webinars
AVBCC COVID-19 Webcast Series
Washington and Public Policy Update
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
AVBCC COVID-19 Webcast Series
Telehealth reimbursement. 340B. Drug pricing negotiations. There’s been a lot of action on healthcare-related proposals in Washington in recent weeks. What’s likely to last, and what is just “political theater”? AVBCC’s panel of experts has the inside scoop.
More Information
August 14, 2020: Update on Research and Investigational Studies: COVID-19 Recovery, the Road Ahead
By
Rob Butcher
;
John de Groot, MD
;
Adam Gadzinski, MD, MS
;
Robyn Gartrell, MD, MS
;
Denise McDade
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
With many clinical trials on hold and COVID-19 studies the only new trials opening up, how are cancer researchers adapting to the new environment? Can lessons from COVID-19 facilitate improved clinical trial recruitment and retention in the future?
More Information
August 13, 2020: Washington and Public Policy Update: COVID-19 Recovery, the Road Ahead
By
Deborah Kamin, RN, PhD
;
Ted Okon, MBA
;
John O’Brien, PharmD, MPH
;
Jayson Slotnik, JD, MPH
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
Telehealth reimbursement. 340B. Drug pricing negotiations. There’s been a lot of action on healthcare-related proposals in Washington in recent weeks. What’s likely to last, and what is just “political theater”? AVBCC’s panel of experts has the inside scoop.
More Information
August 12, 2020: Update From Employers: COVID-19 Recovery, the Road Ahead
By
James Startare
;
Art Taft
;
F. Randy Vogenberg, PhD, RPh, FASHP
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
With the chaos in the workplace and in healthcare caused by the COVID-19 pandemic, experts predict that most major employers will not be looking to add any more disruption with significant changes to their benefit plans for 2021.
More Information
August 11, 2020: Update on Pharmaceutical Manufacturers: COVID-19 Recovery, the Road Ahead
By
Marianne Gandee
;
Gerry Gleeson, MBA
;
Rena Goins
;
Arthur Hirt
;
Alan Tubbs
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
Initiatives to expand patient access programs, strategies to secure the supply chain, and updates on vaccine trials: leaders from top pharmaceutical manufacturers discussed their companies’ ongoing response to the worldwide pandemic in this AVBCC webcast.
More Information
Revenue Cycle Management Update
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
When oncology practices, ranging from small community clinics to larger hospital-based programs, were required to adapt their systems virtually overnight in response to the COVID-19 health crisis, almost no one anticipated that these would be long-term changes. However, as September approaches with no end in sight, it has become clear that oncologists will need to adapt revenue cycle management to long-term pandemic-related changes.
More Information
August 4, 2020: Revenue Cycle Management Update: COVID-19 Recovery, the Road Ahead
By
Parag Shah
;
Nirav Shah, MBA
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
When oncology practices, ranging from small community clinics to larger hospital-based programs, were required to adapt their systems virtually overnight in response to the COVID-19 health crisis, almost no one anticipated that these would be long-term changes. However, as September approaches with no end in sight, it has become clear that oncologists will need to adapt revenue cycle management to long-term pandemic-related changes.
More Information
Managed Care Update
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
One of the most significant questions for payers in the COVID-19 health ecosystem is, “Will reimbursement parity for telehealth services continue?” Leading representatives of major managed care organizations debate the prospects.
More Information
Comprehensive Cancer Centers and IDNs
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
From shuttered laboratory experiments and interrupted clinical trial enrollments to a “shadow curve” of delayed cancer diagnoses, comprehensive cancer centers and integrated delivery networks (IDNs) across the country continue to grapple with the fallout from COVID-19.
More Information
Update from Community Cancer Providers
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
As many full-service hospitals and health systems remain overwhelmed due to the COVID-19 pandemic, community cancer providers have been able to offer certain services to patients that may not be available at other institutions. How have these providers adapted to meet patients’ changing needs, and how are they keeping their doors open under unprecedented pressure?
More Information
July 30, 2020: Update from Community Cancer Care Providers: COVID-19 Recovery, the Road Ahead
By
Michael Diaz, MD
;
Barbara L. McAneny, MD
;
Ted Okon, MBA
;
Kashyap Patel, MD
;
Debra Patt, MD, PhD, MBA
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
As many full-service hospitals and health systems remain overwhelmed due to the COVID-19 pandemic, community cancer providers have been able to offer certain services to patients that may not be available at other institutions. How have these providers adapted to meet patients’ changing needs, and how are they keeping their doors open under unprecedented pressure?
More Information
July 29, 2020: Comprehensive Cancer Care Centers and Integrated Delivery Systems Update: COVID-19 Recovery, the Road Ahead
By
Al B. Benson III, MD
;
Howard “Skip” Burris, III, MD, FACP, FASCO
;
Christian Downs, MHA, JD
;
Timothy Kubal, MBA, MD
;
Julian Schink, MD
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
From shuttered laboratory experiments and interrupted clinical trial enrollments to a “shadow curve” of delayed cancer diagnoses, comprehensive cancer centers and integrated delivery networks (IDNs) across the country continue to grapple with the fallout from COVID-19.
More Information
July 28, 2020: Update from Managed Care Payers: COVID-19 Recovery, the Road Ahead
By
Michael Kolodziej, MD
;
Bryan Loy, MD, MBA
;
Lee N. Newcomer, MD, MHA
;
Steven Peskin, MD, MBA, FACP
;
Michael Sherman, MD, MBA, MS
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
One of the most significant questions for payers in the COVID-19 health ecosystem is, “Will reimbursement parity for telehealth services continue?” Leading representatives of major managed care organizations debate the prospects.
More Information
Patient Advocacy Update
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
As the COVID-19 pandemic stretches into its fifth month in the United States, advocacy groups providing support for patients with cancer are delivering essential support and services, while they worry about the long-term psychosocial impact on these patients and the future of clinical trials.
More Information
Oncology Pharmacy Update
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
Shortages, inventory management, and challenges of in-home care were just a few of the topics in AVBCC’s wide-ranging webinar on how COVID-19 is affecting oncology pharmacy.
More Information
Page 2 of 5
1
2
3
4
5
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma